Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intra-articular versus peri-articular quadruple injection for sacroiliac joint pain
IRCT20210725051977N3Phase 2Completed
- Sponsor
- Islamic Azad University
- Start
- Feb 2023
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
- Countries
- 1
01
Overview
Phase 2, double-blind trial of triamcinolone and bupivacaine in sacroiliac joint disruption (SIJD) (2 arms), sponsored by Islamic Azad University. Primary endpoints: Pain intensity and Side effects. Started Feb 2023; status: completed.
02
Drugs
triamcinolonebupivacaine
03
Conditions
sacroiliac joint disruption (SIJD)
Beyond the preview
Go deeper on IRCT20210725051977N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210725051977N3.